(Pyridin-4-yl)boronic acid → HCID 11244754, compound
Reaction equation
Br[C:2]1[S:6][C:5]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[CH:4][CH:3]=1.[N:20]1[CH:25]=[CH:24][C:23](B(O)O)=[CH:22][CH:21]=1>>[N:20]1[CH:25]=[CH:24][C:23]([C:2]2[S:6][C:5]([N:7]3[CH2:11][C@:10]4([CH:16]5[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]5)[CH2:12]4)[O:9][C:8]3=[O:19])=[CH:4][CH:3]=2)=[CH:22][CH:21]=1Participants
3
Procedure
The title compound was prepared by a method analogous to that described in Example 1 from (R)-3′-(5-bromo-thiophen-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and pyridine-4-boronic acid. The title compound (34 mg) was obtained as a pale-yellow solid, m/z 342 (MH+).
Workup
- customThe title compound was prepared by a method analogous to
Sources & evidence
- ORD record
- ord-96c0fb59c06e4bdd8c624e8db9a162e3
- Source dataset
- uspto-grants-2009_04
- Patent number
- US07514567B2
Reaction notes
Loading…